Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,895.20
(
0.09%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.13
(
-0.93%
)
Bitcoin
76,254.51
(
-0.10%
)
News Focus
News Focus
Post# of 257432
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

NP1986

Send PM Follow Ignore
Followers 6
Posts 541
Boards Moderated 0
Alias Born 06/07/2011

NP1986

Re: mcbio post# 147075

Tuesday, 08/14/2012 7:54:07 PM

Tuesday, August 14, 2012 7:54:07 PM

Post# of 257432

Koch claims the sustained decrease in blood pressure with 797 treatment may actually be beneficial to the drug's profile. In pre-clinical animal models, ARRY has increased OS in CHF animal models with 797.



Koch also mentioned that GSK has a p38 inhibitor in a trial for ACS. I believe this is the one:
http://www.clinicaltrials.gov/ct2/show/NCT00910962?term=p38&recr=Open&rank=11

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today